Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market - Global Outlook and Forecast 2021-2027

April 2021 | 107 pages | ID: GD53E51BF59AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in Global, including the following market information:

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastroesophageal Reflux Disease (GERD) Drugs and Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, By Type, 2020 (%)

• Medication
• Minimally Invasive Surgery
• Invasive Surgery

China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, By Application, 2020 (%)

• Heartburn
• Acid reflux disorders

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• AstraZeneca, Plc.
• Addex Therapeutics
• Takeda Pharmaceutical Company Limited
• Rottapharm (Meda AB)
• Pfizer, Inc.
• Eisai Co. Ltd.
• The Procter & Gamble Company
• Mederi Therapeutics
• Aros Pharma
• Torax Medical, Inc.
• BD
• EndoGastric Solutions
• Medigus Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES OVERALL MARKET SIZE

2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size: 2021 VS 2027
2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players in Global Market
3.2 Top Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies Ranked by Revenue
3.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Companies
3.4 Top 3 and Top 5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players in Global Market
  3.6.1 List of Global Tier 1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Markets, 2021 & 2027
  4.1.2 Medication
  4.1.3 Minimally Invasive Surgery
  4.1.4 Invasive Surgery
4.2 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue & Forecasts
  4.2.1 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2021
  4.2.2 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2022-2027
  4.2.3 By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2021 & 2027
  5.1.2 Heartburn
  5.1.3 Acid reflux disorders
5.2 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue & Forecasts
  5.2.1 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2021
  5.2.2 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2022-2027
  5.2.3 By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2021 & 2027
6.2 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue & Forecasts
  6.2.1 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2021
  6.2.2 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2022-2027
  6.2.3 By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2027
  6.3.2 US Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.3.3 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.3.4 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2027
  6.4.2 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.4.3 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.4.4 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.4.5 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.4.6 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.4.7 Nordic Countries Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.4.8 Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2027
  6.5.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.5.3 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.5.4 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.5.5 Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.5.6 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2027
  6.6.2 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.6.3 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2027
  6.7.2 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.7.3 Israel Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.7.4 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027
  6.7.5 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AstraZeneca, Plc.
  7.1.1 AstraZeneca, Plc. Corporate Summary
  7.1.2 AstraZeneca, Plc. Business Overview
  7.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.1.4 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.1.5 AstraZeneca, Plc. Key News
7.2 Addex Therapeutics
  7.2.1 Addex Therapeutics Corporate Summary
  7.2.2 Addex Therapeutics Business Overview
  7.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.2.4 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.2.5 Addex Therapeutics Key News
7.3 Takeda Pharmaceutical Company Limited
  7.3.1 Takeda Pharmaceutical Company Limited Corporate Summary
  7.3.2 Takeda Pharmaceutical Company Limited Business Overview
  7.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.3.5 Takeda Pharmaceutical Company Limited Key News
7.4 Rottapharm (Meda AB)
  7.4.1 Rottapharm (Meda AB) Corporate Summary
  7.4.2 Rottapharm (Meda AB) Business Overview
  7.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.4.4 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.4.5 Rottapharm (Meda AB) Key News
7.5 Pfizer, Inc.
  7.5.1 Pfizer, Inc. Corporate Summary
  7.5.2 Pfizer, Inc. Business Overview
  7.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.5.4 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.5.5 Pfizer, Inc. Key News
7.6 Eisai Co. Ltd.
  7.6.1 Eisai Co. Ltd. Corporate Summary
  7.6.2 Eisai Co. Ltd. Business Overview
  7.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.6.4 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.6.5 Eisai Co. Ltd. Key News
7.7 The Procter & Gamble Company
  7.7.1 The Procter & Gamble Company Corporate Summary
  7.7.2 The Procter & Gamble Company Business Overview
  7.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.4.4 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.7.5 The Procter & Gamble Company Key News
7.8 Mederi Therapeutics
  7.8.1 Mederi Therapeutics Corporate Summary
  7.8.2 Mederi Therapeutics Business Overview
  7.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.8.4 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.8.5 Mederi Therapeutics Key News
7.9 Aros Pharma
  7.9.1 Aros Pharma Corporate Summary
  7.9.2 Aros Pharma Business Overview
  7.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.9.4 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.9.5 Aros Pharma Key News
7.10 Torax Medical, Inc.
  7.10.1 Torax Medical, Inc. Corporate Summary
  7.10.2 Torax Medical, Inc. Business Overview
  7.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.10.4 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.10.5 Torax Medical, Inc. Key News
7.11 BD
  7.11.1 BD Corporate Summary
  7.11.2 BD Business Overview
  7.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.11.4 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.11.5 BD Key News
7.12 EndoGastric Solutions
  7.12.1 EndoGastric Solutions Corporate Summary
  7.12.2 EndoGastric Solutions Business Overview
  7.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.12.4 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.12.5 EndoGastric Solutions Key News
7.13 Medigus Ltd.
  7.13.1 Medigus Ltd. Corporate Summary
  7.13.2 Medigus Ltd. Business Overview
  7.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Major Product Offerings
  7.13.4 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (2016-2021)
  7.13.5 Medigus Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Opportunities & Trends in Global Market
Table 2. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers in Global Market
Table 3. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints in Global Market
Table 4. Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in Global Market
Table 5. Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
Table 9. List of Global Tier 1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca, Plc. Corporate Summary
Table 31. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 32. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 33. Addex Therapeutics Corporate Summary
Table 34. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 35. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 36. Takeda Pharmaceutical Company Limited Corporate Summary
Table 37. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 38. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 39. Rottapharm (Meda AB) Corporate Summary
Table 40. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 41. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 42. Pfizer, Inc. Corporate Summary
Table 43. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 44. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 45. Eisai Co. Ltd. Corporate Summary
Table 46. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 47. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 48. The Procter & Gamble Company Corporate Summary
Table 49. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 50. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 51. Mederi Therapeutics Corporate Summary
Table 52. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 53. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 54. Aros Pharma Corporate Summary
Table 55. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 56. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 57. Torax Medical, Inc. Corporate Summary
Table 58. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 59. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 60. BD Corporate Summary
Table 61. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 62. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 63. EndoGastric Solutions Corporate Summary
Table 64. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 65. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)
Table 66. Medigus Ltd. Corporate Summary
Table 67. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Offerings
Table 68. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Type
Figure 2. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Application
Figure 3. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2020
Figure 8. By Type - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 12. US Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 16. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 17. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 24. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 28. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 30. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share, 2016-2027
Figure 33. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)